Key Insights

Highlights

Success Rate

94% trial completion (above average)

Published Results

128 trials with published results (24%)

Research Maturity

354 completed trials (67% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

4.1%

22 terminated out of 531 trials

Success Rate

94.1%

+7.6% vs benchmark

Late-Stage Pipeline

26%

140 trials in Phase 3/4

Results Transparency

36%

128 of 354 completed with results

Key Signals

128 with results94% success22 terminated

Data Visualizations

Phase Distribution

458Total
Not Applicable (225)
Early P 1 (8)
P 1 (26)
P 2 (59)
P 3 (42)
P 4 (98)

Trial Status

Completed354
Unknown61
Recruiting41
Not Yet Recruiting28
Terminated22
Withdrawn10

Trial Success Rate

94.1%

Benchmark: 86.5%

Based on 354 completed trials

Clinical Trials (531)

Showing 20 of 20 trials
NCT07740564Phase 3Not Yet RecruitingPrimary

Phase III Study of OT202 in Treating Moderate to Severe Dry Eye

NCT07705893Not ApplicableRecruitingPrimary

Treating Contact Lens Discomfort With Varenicline Solution Nasal Spray 0.03mg

NCT07722624Phase 4Active Not RecruitingPrimary

A Single Center, Open-Label Study to Evaluate the Ability of the TearScience™ LipiView™ II Ocular Surface Interferometer and the Keratograph® 5M to Detect Tear Film Stability Utilizing Miebo®

NCT07453212Not ApplicableEnrolling By InvitationPrimary

Microbiome-Focused Food Supplement for Evaporative Dry Eye Due to Meibomian Gland Dysfunction

NCT07413172Phase 2RecruitingPrimary

Autologous Serum Tears With Hyaluronate vs Balanced Salt Solution for Moderate-to-Severe Dry Eye

NCT07706231Not ApplicableNot Yet Recruiting

A Study of Full-Spectrum Screen Lighting for Reducing Screen-Related Eye Fatigue and Dry Eye

NCT07155070Phase 4RecruitingPrimary

Efficacy of Kera Sol Tears on Signs and Symptoms of Surgical Temporary Ocular Discomfort Syndrome (STODS) in Subjects Following LASIK

NCT07089511Not ApplicableCompletedPrimary

Cord Blood Platelet Poor Plasma Eye Drops

NCT07632534Not ApplicableRecruiting

Study of Proteomic Factors in Patients With Severe Dry Eye Syndrome Treated With Autologous Serum Eye Drops.

NCT06346340Phase 4CompletedPrimary

A Study to Evaluate the Effect of Miebo™ on Preoperative Biometry/Keratometry and Postoperative Refractive Accuracy

NCT07679685Phase 4Not Yet RecruitingPrimary

Perfluorohexyloctane Eye Drops vs. Sodium Hyaluronate for Video Display Terminal-Associated Dry Eye

NCT07675460Not ApplicableCompletedPrimary

Systemic Isotretinoin Therapy and Eye

NCT04418999Early Phase 1Completed

Safety and Efficacy of Intracanalicular Dexamethasone Compared to Loteprednol Etabonate in Patients With Keratoconus

NCT07659626Not Yet RecruitingPrimary

Long-term Effects of Acoltremon vs. Control in Dry Eye Disease

NCT07657858Not ApplicableRecruitingPrimary

Effect of Dry Eye Treatment on Corneal Astigmatism Measurements

NCT06903611Phase 3Not Yet Recruiting

Phase III Study of Topical Fibrinogen-Depleted Human Platelet Lysate Compared to Placebo for Moderate to Severe Dry Eye

NCT03414645Phase 1CompletedPrimary

Topical Fibrinogen-Depleted Human Platelet Lysate in Patients With Dry Eye Secondary to Graft vs. Host Disease

NCT07201493Not ApplicableCompleted

Evaluation of New Color Temperature Adjustment Mode in Preventing Dry Eye and Visual Fatigue

NCT07640867Phase 1CompletedPrimary

RCI001 Eye Drops 0.25% in Healthy Adult Male Participants

NCT05481450Not ApplicableCompletedPrimary

Efficacy and Safety Safety of Nutritears® in Adults With Dry Eye Syndrome

Scroll to load more

Research Network

Activity Timeline